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Objectives: To investigate firstly whether flow-dependent vasodilation is maintained in vein grafts, and secondly whether 
nitric oxide donors dilate vein grafts to improve the flow through graft stenoses. 
Design, materials and methods: The vasodilatation of mature patent vein grafts, in response to reactive hyperaemia 
and glyceryl trinitrate (GTN), was assessed by the change in external diameter using duplex ultrasonography. The 
severity (ratio of proximal systolic velocity, V1, to peak systolic velocity at the stenosis, V2, of vein graft stenoses was 
determined by duplex ultrasonography before and after 24 h of local application of GTN patches. 
Results: In post-occlusion hyperaemia the diameter of patent distal vein grafts (n= 7) increased to a maximum of 
112 +_ 1.9% of resting diameter after 2 rain, p = 0.026. The diameter increased further to 117 ± 2.5% of the resting value 
5 rain after oral GTN (n = 5), p = 0.007. The velocity ratio, V2/V1, through graft stenoses (n = 6) decreased by 20 ± 5% 
after application of GTN patches, principally as a result of reduction in V2, mean difference 0.8, p =0.15. The changes 
in response to GTN were more evident for proximal than distal vein graft stenoses. 
Conclusion: Flow-induced vasodilatation responses, which have been attributed to the endothelial release of nitric oxide, 
are maintained in patent vein grafts: the grafts dilate even further in response to GTN. The application of GTN patches 
close to a vein graft stenosis appears to reduce the velocity ratio through vein graft stenoses. GTN patches might be used 
to reduce the risk of graft occlusion when there is a delay between the detection and the treatment of haemodynamically 
signifi'cant graft stenoses. 
Key Words: Vein graft; Stenosis; Nitric oxide; Hyperaemia; Glyceryl trinitrate. 
Introduction 
Many changes occur in the saphenous vein graft as 
it adapts to the new haemodynamic environment of
an arterial bypass graft. These changes include the 
thickening of the vessel wall and changes in dia- 
meter. 1 Most of the changes in vessel diameter occur 
during the first 3 months after implantation and are 
related to the new shear stresses imposed on the 
graft. 1Many would consider that following this first 
period of adaptation the matured vein graft was 
maintained at a fixed diameter, not amenable to 
further regulation. Studies of excised vein grafts 
have provided conflicting evidence on this matter. 
In vitro studies have shown that excised aorto- 
coronary vein grafts maintain endothelium-de- 
pendent relaxation responses. 2 In contrast, similar 
studies of excised femorodistal vein grafts have 
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indicated that mature infrainguinal vein grafts do 
not maintain their endothelium-dependent r laxation 
responses. 3 The superficial anatomy of many of these 
infrainguinal vein grafts suggests that regulation of 
vein graft diameter could be studied in vivo. The 
ultrasonographic techniques for in vivo studies have 
been described by Celermajer et al. 4 These authors 
have used ultrasonography to demonstrate the in- 
creased iameter of the femoral artery in response to 
hyperaemic flow. 4 This flow-dependent vasodilatation 
has been attributed to the increased flow stimulating 
the production of nitric oxide from endothelium, 
with the nitric oxide triggering vasorelaxation f the 
underlying smooth muscle. In the presence of factors 
which injure endothelium, hypercholesterolaemia and 
smoking, the flow-dependent relaxation of the fem- 
oral artery is blunted. 4 
Here, we have investigated the responses of infra- 
inguinal vein grafts to hyperaemic flow or nitric oxide 
donors (e.g. glyceryl trinitrate) in vivo. In subsequent 
investigations we have attempted to exploit hese re- 
sponses to regulate graft diameter temporarily and 
improve the flow characteristics through vein graft 
stenoses. 
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Table 1. Hyperaemic responses in patients with patent vein grafts. 
Patient Age Graft type Age of Systolic ABPI Serum Graft d Max post- Peak post- 
graft BP cholesterol at rest occlusion d occlusion d 
(months) (mmHg) (mM) (ram) (mm) at (s) 
Max d after 
GTN (mm) 
A 74 Femoropopliteal in situ 9 155 1 5.3 5.1 5.9 120 6.1 
B 67 Femorotibial reversed 9 170 1 6.9 6.7 7.4 120 7.6 
C 69 Femoropopliteal reversed 6 162 1 6.6 7.0 7.4 120 7.7 
D 72 Femorotibial in situ 6 140 0.9 5.9 5.2 6.1 120 6.4 
E 72 Femorotibial in situ 9 160 0.9 5.5 6.9 7.7 90 nd 
F 64 Femorotibial reversed 6 135 1 5.3 6.8 7.2 160 nd 
G 57 Femorotibial reversed 6 125 1 6.1 9.5 11.2 120 11.5 
All patients were male; BP = blood pressure, ABPI = Ankle brachial pressure index, d = diameter [maximum (max) diameter refers to that 
achieved following reactive hyperaemia or glyceryl trinitrate (GTN)], nd=not done. 
Table 2. Patients with vein graft stenosis receiving GTN patches. 
Patient Age Sex Graft type Site of stenosis Age of graft (months) Severity of stenosis 
1 74 F Femorotibial insitu Proximal anastomosis 3 70% 
2 82 M Femorotibioperoneal trunk Distal graft 3 90% 
3 79 F Femorotibial insitu Proximal graft 3 70% 
4 80 F Femorotibial insitu Distal graft 3 90% 
5 82 M Femoroperoneal in s i tu  Proximal graft 1 50% 
6 70 M Femorotibial insitu Proximal anastomosis 3 70% 
Patients and Methods 
From January 1992 all patients undergoing vein bypass 
at Charing Cross Hospital were entered into a graft 
surveillance programme using colour-flow Doppler 
ultrasonography. 5 Regular graft surveillance was per- 
formed by an experienced vascular technologist using 
an Ultramark 9 HDI  scanner (Advanced Technology 
Laboratories, Bothell, Washington). From these we 
selected seven patients with widely patent grafts at 6 
or 9 months after implantation for in vivo studies of 
vein graft vasodilatation: the patients' characteristics 
are shown in Table 1. For this first study we excluded 
patients with diabetes, patients taking nitrates and 
smokers. Smoking status was monitored using whole 
blood carboxyhaemoglobin levels. We also selected 
six patients with haemodynamical ly  significant graft 
stenoses (four proximal stenoses, two distal stenoses) 
to investigate whether flow through the stenosis could 
be improved by the application of glyceryl trinitrate 
(GTN) patches: the characteristics of these patients are 
shown in Table 2. Both these studies were approved 
by the local ethical committee. 
Vasodilatation of mature vein grafts 
The protocol for these investigations was adapted from 
that of Celemajer et al. 4 Patients rested supine for 
15 min before investigations. The vein graft was im- 
aged in longitudinal section in the adductor canal 
using a 5MHz probe. The internal and external dia- 
meters were measured, using a mean of three readings. 
A dual channel laser-Doppler blood flow monitor 
(Moor Instruments, Model MBF3/D Exeter, U.K.) was 
used to measure cutaneous capillary flow on the lateral 
aspect of the cal l  10 cm distal to the knee joint, and 
basal flow (cellular flux) recorded. A thigh cuff was 
inflated to 50 mmHg above the systolic blood pressure 
and the inflation maintained for 4 min, during which 
period flow in the vein graft and cell flux through the 
calf skin capillaries fell to zero. Following release of 
the thigh cuff the internal and external diameters of 
the vein graft were measured at 30 s intervals for the 
first 2 min and again at 3, 4, 7 and 10 min. The laser- 
Doppler tracing confirmed the hyperaemic response 
in the skin capillaries. The patient then rested for at 
least 30 min before further investigations. The further 
investigations included monitoring the diameter of the 
vein graft after 400 ~tg GTN, given as sublingual spray, 
and assessment of measurement reproducibility. 
Assessment of the effect of glyceryl trinitrate on vein 
graft stenoses 
The details of the six vein graft stenoses which were 
assessed are given in Table 2. Following the detection 
of haemodynamical ly  significant graft stenoses in the 
duplex surveillance programme,  patients were ad- 
mitted to hospital for further investigations and 
planned graft revision. Stenosis severity was assessed 
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from V2/V1, the ratio of the peak systolic velocity at 
the site of stenosis (V2) in comparison to the peak 
systolic velocity in the adjacent normal proximal vein 
graft (V1). 5 In six patients (Table 2), a GTN patch 
(10 mg, Nitro-Dur, Schering-Plough) was placed on 
the skin at the site overlying the graft stenosis. After 
24 h the graft was reassessed by the same vascular 
tedmologist who had detected the stenosis the pre- 
vious day (M.E). 
Measurement errors 
The reproducibility of arterial dimensions measured 
by ultrasonography as been investigated previously. 6 
Similar methods were used to assess the repeatability 7 
of vein graft diameters, with blinded observers meas- 
uring graft diameters on six patients on two separate 
occasions: for the external diameter of a vein graft 
in the adductor canal using a single observer the 
repeatability was 0.4 mm. Intraobserver variation in 
measurement of systolic velocity ratios (V2/V1) was 
investigated by repeated measurement on two vein 
graft stenoses. The position of the stenosis was iden- 
tified by sharp changes in the colour-flow saturation. 
The peak systolic velocity at the site of maximal sten- 
osis (V2) and at a normal proximal site (V1) were 
measured by the same observer on five occasions: for 
a mean velocity ratios of 2.5 and 5.8 the repeatability 
was 0.4 and 0.5, respectively. 
Analysis of results 
Results were compared using a Students t-test and are 
presented as mean ± S.D. 
Results 
Response of vein grafts to reactive hyperaemia 
Parallel recordings were made of vein graft diameter 
and cutaneous capillary flow. These are shown for a 
single patient in Fig. 1. Peak vein graft external dia- 
meter was observed 120 s after release of the thigh 
cuff, whereas the increased flow in cutaneous ca- 
pillaries was observed 30 s after release of the thigh 
cuff. This difference in the time of response was ob- 
served in all patients. The response of vein graft ex- 
ternal diameter was very reproducible: in one patient, 
with the largest diameter vein graft, the hyperaemic 
test was repeated eight times and the mean results 
(±S.D.) are shown in Fig. 2. The resting and peak 
diameters for all patients are shown in Table 1: there 
was a significant increase to 112 ± 1.9% (mean ± s.~.M.) 
of the resting diameter 120 s after release of the oc- 
cluding thigh cuff, p = 0.026, mean difference 0.81 ram. 
The diameter of the vein graft could be increased even 
further 5 min after sublingual GTN spray, when the 
external vein graft diameter had increased to 
117_+ 2.5% (mean_+ S.E.M.) of the resting diameter, p-- 
0.007, mean difference 1.16 mm (maximum diameters 
are given in Table 1). These results confirm that patent 
vein grafts can modulate their diameter in response 
to both flow and GTN. 
Effect of GTN on flow through vein graft stenoses 
The patients chosen for study had stenoses of varying 
severity, with V2/V1 ratios ranging from 2.5-6.3. Ap- 
plication of a GTN patch had no systematic effect on 
the peak systolic velocity proximal to a graft stenosis 
(Fig. 3a). Peak systolic velocity (V2) at the site of 
the vein graft stenosis fell in five of the six patients 
following GTN treatment, mean difference 0.8 (p-- 
0.15, Fig. 3b). Velocity ratio (V2/V1) was reduced in 
all six cases 24 h after application of a slow release 
GTN patch (Fig. 4). The mean velocity ratio before 
therapy was 4.6_+0.5 and fell to 3.2+0.6 following 
GTN (p = 0.04, paired t-test). The reduction in velocity 
ratio was least for the two stenoses ituated at distal 
sites in the vein grafts (patients 3 and 4, Fig. 4). 
Discussion 
The success of saphenous vein as an arterial bypass 
conduit may depend in part on the ability of the 
graft to simulate the responses of healthy arteries to 
variations in blood flow. In healthy arteries increased 
flow stimulates the endothelial synthesis of nitric oxide 
(endothelium-derived r laxing factor). Nitric oxide dif- 
fuses into the lumen and underlying smooth muscle, 
where it interacts with the active site of guanylate 
cyclase in platelets and vascular smooth muscle cells 
to limit platelet activation and effect smooth muscle 
cell relaxation, respectively. 8 Therefore dilatation is the 
normal response of arteries to increased flow. Similarly 
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Fig. 1. Parallel responses of cutaneous capillaries and a vein graft to reactive hyperaemia. The upper panel shows the laser-Doppler 
recording of cellular flux in the cutaneous capillaries of the lateral calf, and the lower panel shows the change in external diameter Of the 
vein graft in the adductor canal. 
the nitrate family of drugs, of which GTN is a proto- 
type, bypass the endothelium and act as nitric oxide 
donors which cause the relaxation of vascular smooth 
muscle. These responses have been explored elegantly 
in vivo by Deanfield and colleagues. 4 The superficial 
femoral artery increases to 109% of the resting diameter 
90 s after the start of post-occlusive hyperaemia, and 
to 113% of the resting diameter after administration 
of sublingual GTN. 4 The production of endothelial 
nitric oxide is much lower in saphenous vein than in 
femoral artery, but the production of endothelial nitric 
oxide may be increased as one of the adaptations of 
saphenous vein to arterial flow. 9 Here we have shown 
that 6-9 months after implantation, patent saphenous 
vein grafts have developed responses to flow and GTN 
similar to those observed in healthy native arteries. 
Even diseased vein grafts, with haemodynamical ly 
significant stenoses, maintain some responsiveness to 
GTN. 
The magnitude of both the endothelium-dependent 
(hyperaemic) and endothelium-independent (GTN) di- 
latation responses we observed in vein grafts were 
greater than those observed in femoral arteries. There 
are several reasons that might contribute to the mag- 
nitude of the observed responses in 6-9-month-old vein 
grafts. Firstly, these grafts are "new" to the arterial cir- 
culation; and both endothelium-dependent andendo- 
thelium-independent responses of femoral and brachial 
arteries are greater in children than in adults .4 Secondly, 
we took considerable care to exclude smokers. Smoking 
is an important factor associated with endothelial dys- 
function in both the femoral artery and saphenous vein 
and could dampen the response to reactive hy- 
peraemia. 4'1° Thirdly, in vein grafts the maximum dia- 
meter was not reached until 2 min after release of thigh 
cuff occlusion or until 3-5 min after sublingual GTN, 
whereas previous studies have monitored femoral ar- 
tery diameter 90 s after release of the occlusive thigh 
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Fig. 2. Reproducibility of the dilatation of vein grafts in response to reactive hyperaemia. The hyperaemic response test was performed 
eight times by a single observer. Maximum dilatation was observed after 120 s. Results are shown as mean ± S.D. 
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Fig. 3. Peak systolic velocities in the failing vein graft before and after the application of GTN patches. In (a) the peak systolic velocity 
proximal to the stenosis is shown, whereas in (b) the peak systolic velocity at the stenosis is shown. 
cuf f .  4 Interestingly, the peak hyperaemic response in cu- 
taneous vessels was observed within i min of release 
of the occlusive thigh cuff (Fig. 1). Similar biological 
mechanisms are thought  to control f low-stimulated 
vasodi latation i capillaries and arteries. The slower re- 
sponse of arteries and vein grafts might  be attr ibuted to 
their thicker walls, with intimal thickening prov id ing an 
addit ional diffusion barrier for nitric oxide in vein grafts. 
The max imum increase in vein graft diameter, 17%, after 
GTN translates into a 37% increase in lumenal  area. 
Previous in vitro studies of excised vessels have 
indicated that there may be differences in the endo- 
the l ium-dependent  responses of aortocoronary and 
infrainguinal vein grafts. 2"3 Ku et aI. showed that endo- 
the l ium-dependent  responses were present in patent 
aortocoronary vein grafts f rom patients undergo ing  
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Fig. 4. The influence of GTN patches on the velocity gradient 
across vein graft stenoses. The GTN patches were applied for 24 h. 
cardiac transplantation. 2 We have shown that endo- 
thelium-dependent responses are observed in infra- 
inguinal vein grafts in vivo, whereas Park et al. failed 
to demonstrate hese responses invitro using segments 
of vein removed at revision of failing bypasses. 3 Many 
different factors cause endothelial dysfunction and 
some of these, particularly smoking, are the same 
factors associated with vein graft occlusion and fail- 
ure. 1°'1~ This might provide some explanation for the 
contradictory results obtained, with the poor endo- 
thelium-dependent responses in failing infrainguinal 
vein grafts 3 being attributable to smoking, hyper- 
tension, hypercholesterolaemia and other factors as- 
sociated with endothelial dysfunction. Such studies 
underscore the possible associations between endo- 
thelial function and vein graft patency. 
Even if some of the endothelium-dependent re- 
sponses of the failing vein graft are considerably im- 
paired, the endothelium-independent responses, 
which include dilatation in response to GTN, may be 
better preserved. Certainly the local application of 
GTN appears to have been beneficial in our small 
series of patients with vein graft stenosis. Nitrates 
have both systemic and local effects: we chose the GTN 
patches for their slow release properties, providing a 
sustained dose with minimal side effects. These 
patches had a significant effect: in all six patients the 
velocity ratio across the graft stenosis was reduced 
after 24h of a GTN patch. Interestingly, the im- 
provement was most marked for the four proximal 
graft stenoses. There are at least two possible ex- 
planations for this observation. Firstly, these grafts 
were all in situ and this disparity of responses could 
be explained if the proximal saphenous vein were 
more sensitive to nitrate-mediated dilatation, although 
there is little evidence in Table 1 to support this. 
Secondly, in experimental studies intimal hyperplasia 
and vasomotor dysfunction increases towards the 
distal anastomosis of the vein graft. 12 A much larger 
number of patients would be required to confirm the 
different responsiveness to GTN of proximal and distal 
vein graft stenoses. 
In conclusion, we have shown that patent infra- 
inguinal vein grafts exhibit both endothelium-de- 
pendent and endothelium-independent vasodilator 
responses. The endothelium-independent responses 
are preserved, at least in part, in failing vein grafts. 
The preservation of this response can be exploited to 
provide temporary palliation, using GTN patches, of 
vein graft stenoses between their detection and defin- 
itive treatment. 
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